India News | Reuters | Thursday May 27, 2021
Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild COVID-19, as India grapples with a shortage of medicines and vaccines needed to effectively tackle a devastating second wave of the pandemic.
www.ndtv.com